Quantitative Systematic Strategies’s AbbVie ABBV Stock Holding History

Quantitative Systematic Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,386	Closed	-$381K	–	6
2021 Q2	$381K	Sell	3,386 -11,211	-77%	-$1.26M	0.13%	288
2021 Q1	$1.58M	Buy	14,597 +2,703	+23%	+$289K	0.24%	129
2020 Q4	$1.27M	Sell	11,894 -18,734	-61%	-$1.8M	0.18%	181
2020 Q3	$2.68M	Buy	30,628 +27,611	+915%	+$2.6M	0.47%	51
2020 Q2	$296K	Buy	+3,017	New	+$266K	0.06%	420
2020 Q1	–	Sell	-4,346	Closed	-$385K	–	245
2019 Q4	$385K	Buy	4,346 +1,615	+59%	+$134K	0.06%	386
2019 Q3	$207K	Buy	+2,731	New	+$187K	0.05%	404
2018 Q3	–	Sell	-2,555	Closed	-$237K	–	607
2018 Q2	$237K	Buy	+2,555	New	+$250K	0.04%	520
2015 Q2	–	Sell	-6,868	Closed	-$400K	–	496
2015 Q1	$400K	Buy	+6,868	New	+$415K	0.11%	258

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantitative Systematic Strategies's ABBV Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 3,386 shares — an estimated $381K sold.

Quantitative Systematic Strategies first reported a position in ABBV in Q1 2015 and held it in 9 quarters. The position peaked at $2.68M in Q3 2020. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Quantitative Systematic Strategies reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 3,386 AbbVie shares in Q3 2021, an estimated $381K.
Quantitative Systematic Strategies first reported a position in AbbVie in Q1 2015 and held it in 9 quarters.
Quantitative Systematic Strategies's AbbVie position peaked at $2.68M in Q3 2020.
2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.